Safety and immunogenicity of mRNA-based seasonal influenza vaccines formulated to include multiple A/H3N2 strains with or without the B/Yamagata strain in US adults aged 50–75 years: a phase 1/2, open-label, randomised trial
| Autor: | Hsu, Denise a, *, Jayaraman, Akila a, Pucci, Alicia a, Joshi, Riya a, Mancini, Kevin a, Chen, Hui Ling a, Koslovsky, Kindra a, Mao, Xuezhou a, Choi, Angela a, Henry, Carole a, Vakil, Jignesh a, Stadlbauer, Daniel a, Jorquera, Patricia a, Arunkumar, Guha Asthagiri a, Sanchez-Crespo, Nelia E b, Wadsworth, L Tyler c, Bhupathy, Vellore d, Du, Evelyn a, Avanesov, Andrei a, Ananworanich, Jintanat a, Nachbagauer, Raffael a |
|---|---|
| Zdroj: | In The Lancet Infectious Diseases January 2025 25(1):25-35 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|